Sign in
Taking peopleNo phase

Wearable ultrasound sensor for imaging deep vein blood clots

Tests a wearable ultrasound sensor for imaging in adults, including deep vein thrombosis.

Key facts

Who runs it
Chinese PLA General Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Clinical Application of Wearable Ultrasound Sensors
Status
Recruiting
People taking part
300 people, planned
Started
15 Aug 2025
Planned end
30 Sept 2026
Type of study
Observational
Treatments tested
  • This study is designed to assess the non-inferiority of a novel ultrasound imaging technique, rather than to evaluate a therapeutic intervention.
Record updated
20 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with heart failure, a blood clot in a leg vein (DVT), or who need monitoring in intensive care. It tests a wearable ultrasound sensor.

Age
18 to 70 years
Sex
All sexes
Disease stage
One of three groups. Heart failure: stable HFrEF or HFpEF. DVT: lower-limb DVT confirmed by imaging. ICU: ICU or after-surgery patients needing continuous bedside ultrasound.
Earlier treatment
Heart failure group: on standard therapy. DVT group: taking blood thinners or scheduled for a procedure.

Main reasons for not taking part

  • Ultrasound cannot get clear images through the skin
  • Skin infection, open wound, or implant at the sensor spot
  • Unable to cooperate with monitoring
  • Heart failure group: heart attack or uncontrolled irregular heartbeat in the past 3 months
  • DVT group: active bleeding or severe clotting problems; ICU group: unstable failure of several organs

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age ≥ 18 yrs and able to consent
  • Relevant diagnosis for study arm (heart failure, lower-limb DVT, or ICU monitoring)
  • Adequate acoustic window and intact skin at sensor site; Arm-specific:
  • Heart-failure arm: Clinically stable HFrEF or HFpEF on standard therapy
  • DVT arm: Imaging-confirmed lower-limb DVT, anticoagulated or scheduled for intervention
  • ICU arm: ICU/post-op patient requiring continuous bedside ultrasound

Who cannot take part

  • Local skin infection, open wound, or implant/hardware blocking sensor
  • Heart-failure arm: Acute MI or uncontrolled arrhythmia in past 3 months
  • DVT arm: Active bleeding or severe coagulopathy
  • ICU arm: Unstable multi-organ failure precluding safe monitoring
  • Poor acoustic window preventing interpretable images
  • Inability to cooperate with monitoring; Arm-specific:

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to develop and evaluate a wearable ultrasound imaging sensor for the early diagnosis and real-time monitoring of various diseases, such as cardiovascular conditions and structural abnormalities of superficial organs. With advancements in medical technology, wearable devices have attracted increasing attention for their portability and real-time capabilities.

Treatments tested

  • This study is designed to assess the non-inferiority of a novel ultrasound imaging technique, rather than to evaluate a therapeutic intervention.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Clinical Application on the R&D Purpose of Wearable Ultrasound Sensors:A Single-Center Prospective Study
Plain-language title
Wearable ultrasound sensor for imaging deep vein blood clotsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT07009873, who can take part
Record updated
20 March 2026